We are live on ! Find out more
Antipodes Partners

Antipodes Partners Portfolio holdings

AUM $5.46B Turnover 36.94%
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$5.19B
AUM Growth
+$431M
Cap. Flow
+$355M
Cap. Flow %
6.83%
Top 10 Hldgs %
35.34%
Holding
153
New
23
Increased
48
Reduced
47
Closed
27
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
1.7 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.8 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$130M
2
HTO icon
H2O America
HTO
+$102M
3
DIS icon
Walt Disney
DIS
+$69.5M
4
WDAY icon
Workday
WDAY
+$69M
5
PGR icon
Progressive
PGR
+$60.7M

Sector Composition

Rank Sector Weight
1 Utilities 28.74%
2 Technology 13.47%
3 Healthcare 12.72%
4 Energy 9.26%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALLY icon
26
Ally Financial
ALLY
$11.5B
$89.5M 1.72%
2,281,013
-187,164
-8% -$7.7M
2024 Q3
6 quarters
CART icon
27
Maplebear
CART
$12.1B
$88.4M 1.7%
2,359,573
+1,596,947
+209% +$60.6M
2025 Q3
2 quarters
CRM icon
28
Salesforce
CRM
$203B
$85.7M 1.65%
459,046
+114,010
+33% +$23.6M
2024 Q4
5 quarters
EAT icon
29
Brinker International
EAT
$8.58B
$83.8M 1.61%
586,968
+160
+0% +$24.4K
2025 Q2
3 quarters
WDAY icon
30
Workday
WDAY
$47.4B
$81.1M 1.56%
624,311
+434,653
+229% +$69M
2025 Q2
3 quarters
EVRG icon
31
Evergy
EVRG
$18.8B
$80.6M 1.55%
983,388
+34,155
+4% +$2.7M
2025 Q3
2 quarters
GMED icon
32
Globus Medical
GMED
$10.6B
$77.3M 1.49%
897,607
-9,226
-1% -$828K
2025 Q1
4 quarters
VAL icon
33
Valaris
VAL
$5.82B
$75.6M 1.46%
770,992
+75,987
+11% +$5.92M
2024 Q4
5 quarters
AMT icon
34
American Tower
AMT
$84.5B
$75.4M 1.45%
436,946
+29,789
+7% +$5.36M
2025 Q3
2 quarters
SLB icon
35
SLB Ltd
SLB
$71.8B
$74.4M 1.43%
1,446,935
+749,183
+107% +$36.4M
2025 Q4
1 quarter
VTR icon
36
Ventas
VTR
$43.5B
$64.8M 1.25%
792,378
-64,594
-8% -$5.29M
2024 Q2
7 quarters
DIS icon
37
Walt Disney
DIS
$191B
$63.4M 1.22%
+657,521
New +$69.5M
2026 Q1
0 quarters
KDP icon
38
Keurig Dr Pepper
KDP
$46.5B
$61.8M 1.19%
2,348,581
-39,624
-2% -$1.11M
2025 Q3
2 quarters
NU icon
39
Nu Holdings
NU
$71.2B
$60.3M 1.16%
4,192,952
+785,026
+23% +$12.7M
2023 Q1
12 quarters
PGR icon
40
Progressive
PGR
$124B
$58.3M 1.12%
+294,112
New +$60.7M
2026 Q1
0 quarters
META icon
41
Meta Platforms (Facebook)
META
$1.88T
$55.1M 1.06%
96,266
-82,977
-46% -$53.2M
2025 Q4
1 quarter
ALNY icon
42
Alnylam Pharmaceuticals
ALNY
$31.3B
$48.1M 0.93%
145,310
+97,424
+203% +$33.2M
2022 Q4
13 quarters
HON icon
43
Honeywell
HON
$66.7B
$36.4M 0.7%
161,216
-4,112
-2% -$940K
2025 Q3
2 quarters
EGO icon
44
Eldorado Gold
EGO
$9.45B
$36.1M 0.7%
1,052,142
-613,228
-37% -$25M
2024 Q3
6 quarters
DGX icon
45
Quest Diagnostics
DGX
$26.4B
$31.9M 0.61%
162,589
-9,398
-5% -$1.83M
2025 Q1
4 quarters
ORCL icon
46
Oracle
ORCL
$408B
$31.2M 0.6%
212,117
-27,574
-12% -$4.48M
2025 Q4
1 quarter
PCOR icon
47
Procore
PCOR
$8.9B
$27.3M 0.53%
478,746
-379,065
-44% -$22.4M
2025 Q1
4 quarters
NEM icon
48
Newmont
NEM
$122B
$26.4M 0.51%
243,496
-84,693
-26% -$9.76M
2023 Q1
12 quarters
JNJ icon
49
Johnson & Johnson
JNJ
$610B
$24.7M 0.48%
101,023
-15,783
-14% -$3.68M
2025 Q2
3 quarters
UBS icon
50
UBS Group
UBS
$146B
$22.5M 0.43%
587,054
-303,378
-34% -$13M
2024 Q3
6 quarters

Similar funds

Antipodes Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Antipodes Partners held 153 positions worth $5.19B, up 9.1% from $4.76B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Antipodes Partners deployed $355M of net new capital in Q1 2026, opening 23 new positions and adding to 48 existing holdings. Its largest new stake was NVIDIA: 710,665 shares worth $124M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $53.2M trimmed.

  • Antipodes Partners's largest Q1 2026 buy was NVIDIA: 710,665 shares worth $124M.
  • Antipodes Partners added most to H2O America in Q1 2026, an estimated $102M increase.
  • Antipodes Partners's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $53.2M.
  • Antipodes Partners fully exited Advanced Micro Devices in Q1 2026, selling an estimated $62.8M.
  • Antipodes Partners's ten largest holdings make up 35% of its $5.19B portfolio in Q1 2026.
  • Antipodes Partners opened 23 new positions and closed 27 in Q1 2026.
  • Antipodes Partners's portfolio value rose 9.1% quarter-over-quarter to $5.19B.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.